Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2010 1
2011 5
2012 3
2013 6
2014 6
2015 9
2016 11
2017 10
2018 3
2019 5
2020 9
2021 11
2022 8
2023 8
2024 10
2025 14
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
Exercise-induced pneumomediastinum.
Tobushi T, Hosokawa K, Matsumoto K, Kadokami T. Tobushi T, et al. Among authors: hosokawa k. Int J Emerg Med. 2015 Dec;8(1):43. doi: 10.1186/s12245-015-0089-9. Epub 2015 Dec 1. Int J Emerg Med. 2015. PMID: 26620306 Free PMC article.
A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.
Hosokawa K, Watanabe H, Taniguchi Y, Ikeda N, Inami T, Yasuda S, Murohara T, Hatano M, Tamura Y, Yamashita J, Tatsumi K, Tsujino I, Kobayakawa Y, Adachi S, Yaoita N, Minatsuki S, Todaka K, Fukuda K, Tsutsui H, Abe K; KABUKI Investigators. Hosokawa K, et al. Circulation. 2024 Jan 30;149(5):406-409. doi: 10.1161/CIRCULATIONAHA.123.067528. Epub 2023 Nov 13. Circulation. 2024. PMID: 37956127 Free PMC article. Clinical Trial. No abstract available.
Significance of diffusing capacity of the lungs for carbon monoxide on chronic thromboembolic pulmonary hypertension.
Minatsuki S, Hatano M, Funakoshi K, Taniguchi Y, Adachi S, Inami T, Hosokawa K, Yamashita J, Ogino H, Tsujino I, Yaoita N, Ikeda N, Tanabe N, Shimokawahara H, Kubota K, Shigeta A, Tatsumi K, Horimoto K, Ogihara Y, Dohi Y, Hiraide T, Kawakami T, Ikemiyagi H, Tamura Y, Fukumoto Y, Abe K; CTEPH AC Registry Study Group. Minatsuki S, et al. Among authors: hosokawa k. Thorax. 2026 Aug 14;81(9):913-917. doi: 10.1136/thorax-2025-223670. Thorax. 2026. PMID: 41500847 Free PMC article.
Adult-onset idiopathic peripheral pulmonary artery stenosis.
Tamura Y, Tamura Y, Shigeta A, Hosokawa K, Taniguchi Y, Inami T, Adachi S, Tsujino I, Nakanishi N, Sato K, Sakamoto J, Tanabe N, Takama N, Nakamura K, Kubota K, Komura N, Kato S, Yamashita J, Takei M, Joho S, Ishii S, Takemura R, Sugimura K, Tatsumi K. Tamura Y, et al. Among authors: hosokawa k. Eur Respir J. 2023 Dec 21;62(6):2300763. doi: 10.1183/13993003.00763-2023. Print 2023 Dec. Eur Respir J. 2023. PMID: 38061784 Free PMC article.
Effects of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors on Relationship Between B-Type Natriuretic Peptide and Hemoglobin Levels in Patients With Cardiorenal Anemia Syndrome.
Yoshitake T, Hashimoto T, Matsushima S, Ikuta K, Yamamoto S, Suenaga T, Nakashima S, Kai T, Misumi K, Shinohara K, Fujino T, Katsuki S, Hosokawa K, Kinugawa S, Abe K. Yoshitake T, et al. Among authors: hosokawa k. Cardiovasc Ther. 2025 Nov 6;2025:3143864. doi: 10.1155/cdr/3143864. eCollection 2025. Cardiovasc Ther. 2025. PMID: 41244933 Free PMC article.
JCS/JCC/JACR/JATS 2024 guideline on cardiovascular practice with consideration for diversity, equity, and inclusion.
Tsukada YT, Aoki-Kamiya C, Mizuno A, Nakayama A, Ide T, Aoyama R, Honye J, Hoshina K, Ikegame T, Inoue K, Bando YK, Kataoka M, Kondo N, Maemura K, Makaya M, Masumori N, Mito A, Miyauchi M, Miyazaki A, Nakano Y, Nakao YM, Nakatsuka M, Nakayama T, Oginosawa Y, Ohba N, Otsuka M, Okaniwa H, Saito A, Saito K, Sakata Y, Harada-Shiba M, Soejima K, Takahashi S, Takahashi T, Tanaka T, Wada Y, Watanabe Y, Yano Y, Yoshida M, Yoshikawa T, Yoshimatsu J, Abe T, Dai Z, Endo A, Fukuda-Doi M, Ito-Hagiwara K, Harima A, Hirakawa K, Hosokawa K, Iizuka G, Ikeda S, Ishii N, Izawa KP, Kagiyama N, Umeda-Kameyama Y, Kanki S, Kato K, Komuro A, Konagai N, Konishi Y, Nishizaki F, Noma S, Norimatsu T, Numao Y, Oishi S, Okubo K, Ohmori T, Otaki Y, Shibata T, Shibuya J, Shimbo M, Shiomura R, Sugiyama K, Suzuki T, Tajima E, Tsukihashi A, Yasui H, Amano K, Kohsaka S, Minamino T, Nagai R, Setoguchi S, Terada K, Yumino D, Tomoike H; Japanese Circulation Society Joint Working Group. Tsukada YT, et al. Among authors: hosokawa k. J Cardiol. 2025 Jun;85(6):510-574. doi: 10.1016/j.jjcc.2025.03.002. J Cardiol. 2025. PMID: 40533120 No abstract available.
Activated factor X inhibition ameliorates NF-κB-IL-6-mediated perivascular inflammation and pulmonary hypertension.
Imakiire S, Kimuro K, Yoshida K, Masaki K, Izumi R, Imabayashi M, Watanabe T, Ishikawa T, Hosokawa K, Matsushima S, Hashimoto T, Shinohara K, Katsuki S, Matoba T, Nakamura K, Hirano K, Tsutsui H, Abe K. Imakiire S, et al. Among authors: hosokawa k. Am J Physiol Lung Cell Mol Physiol. 2025 Jul 1;329(1):L183-L196. doi: 10.1152/ajplung.00303.2024. Epub 2025 Jun 13. Am J Physiol Lung Cell Mol Physiol. 2025. PMID: 40514194 Free article.
Cancer as an independent mortality risk in chronic thromboembolic pulmonary hypertension.
Nakamura J, Tsujino I, Masaki K, Hosokawa K, Funakoshi K, Taniguchi Y, Adachi S, Inami T, Yamashita J, Ogino H, Hatano M, Yaoita N, Ikeda N, Shimokawahara H, Tanabe N, Kubota K, Shigeta A, Ogihara Y, Horimoto K, Dohi Y, Kawakami T, Tamura Y, Tatsumi K, Abe K. Nakamura J, et al. Among authors: hosokawa k. J Heart Lung Transplant. 2025 Mar;44(3):339-348. doi: 10.1016/j.healun.2024.10.022. Epub 2024 Oct 30. J Heart Lung Transplant. 2025. PMID: 39486772 Free article.
112 results